You searched for "safety"

471 results found

Intravitreal bevacizumab vs. ranibizumab in the treatment of macular oedema due to BRVO

This is a randomised, prospective, non-inferiority trial of 75 patients with macular oedema due to a branch retinal vein occlusion (BRVO) who received intravitreal injections of ranibizumab or bevacizumab after 1:1 block randomisation. This study is to measure the difference...

Addressing medical risk factors for diabetes and understanding the new systemic treatments

As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...

Glaukos at the Royal College of Ophthalmologists Annual Congress 2019 – Stand 17b

Glaukos, the ophthalmic medical technology company dedicated solely to the transformation of the treatment of glaucoma, is delighted to be attending the Annual Congress in Glasgow in May 2019. Glaukos has a portfolio of cutting edge products including the revolutionary...

Short-term effects of intravitreal bevacizumab on the cornea

Bevacizumab has been extensively used to treat macula oedema and neovascularisation of the retina and it has also been useful in the management of corneal neovascular diseases. This prospective study aimed to provide more information on the effect bevacizumab may...

Effect of voriconazole of vision of healthy volunteers

Voriconazole is a broad spectrum, triazole antifungal agent used for systemic fungal infections. It has a favourable safety profile and is available in both intravenous and oral forms. The commonest adverse drug reactions with voriconazole are changes in visual perception,...

Vital dyes in ophthalmology

This comprehensive review gives an excellent summary of the uses and properties of the different dyes available to aid better visualisation and diagnoses in ophthalmology. The authors clearly display the pharmacological properties, molecular details, osmolarity and indications in clinical ophthalmology...

Short-term outcome after intravitreal ranibizumab injections for ROP

This is an interventional case series study of three premature babies (six eyes) with high risk prethreshold or threshold retinopathy of prematurity (ROP) with plus disease that received intravitreal ranibizumab injections for ROP. All infants received intravitreal ranibizumab injections of...

Intensive cataract training

Cataract surgery is one of the most commonly performed surgical procedures carried out worldwide but there is a steep learning curve and a higher complication rate for trainee surgeons. This study reports on an innovative training programme of combining the...

Use of bovine pericardium for tendon elongation

A retrospective analysis was conducted on all patients treated in one centre with tendon elongation using bovine pericardium (BP) to examine outcomes and long-term safety. The study included 60 patients; 27 unilateral and 33 bilateral cases. Follow-up of one to...

Anterior segment ischaemia (ASI) risk in 3-muscle surgery

The aim of this study was to calculate the risk of clinically evident ASI following simultaneous 3-rectus muscle surgery and safety profile of the same in a relatively large number of patients from a single tertiary care centre. This was...

Ozurdex in epiretinal membrane surgery

This was a prospective multicentre pilot study, looking at the effect of Ozurdex on visual acuity (VA) and central retinal thickness (CRT) in patients undergoing surgery for epiretinal membrane (ERM). Twelve eyes of 12 patients were included in the study....

Nepafenac punctal plugs after cataract surgery: a new alternative?

The nepafenac punctal plug delivery system (N-PPDS) is an experimental L-shaped plug made of nonbiodegradable, preservative-free medical-grade silicone. It can deliver a sustained level of nepafenac for six weeks. This is a prospective, randomised, parallel-arm, double-masked, placebo-controlled, phase II pilot...